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ABSTRACTS 
COMPARATIVE EVALUATION OF SUBLINGUAL LONG ACTING 
NITRATES IN ANGINA PECTORIS 
Andrew Klaus, MD, Barry Zaret, MD, Bertram Pitt,MD, Richard 
S. Ross, MD, FACC 
Johns Hopkins Hospital and University, Baltimore, Maryland 
Ten patients with angina performed two exercise tests on five con- 
secutive days to determine the efficacy and duration of action of 
three sublingual long acting nitrates (LAN): isosorbide dinitrate 5 
mg (ISD), erythrityl tetranitrate 10 mg (ETN), and penaerythitol 
trinitrate 10 mg (PET). In a double blind protocol the mean dur- 
ation of exercise 45 and 100 minutes after administration of IAN 
were compared with the mean duration of exercise 45 minutes after 
placebo and also 4 and 50 minutes after nitroglycerin 0.4 mg. 
Mean duration of exercise 4 minutes after nitroglycerin was 89.3 
seconds compared to 60.5 seconds after placebo (pcO.001); no 
difference from placebo was found 50 minutes after nitroglycerin. 
Mean duration of exercise 45 minutes after ETN, ISD, and PET 
were 89.1, 87.5 and 87.5 seconds respectively and were all dif- 
ferent from placebo (~~0.01). Mean duration of exercise for the 
group 100 minutes after each LAN was not significantly different 
from placebo but 5 of the 10 patients had prolongation at 100 
minutes equal to that at 45 minutes with at least one LAN. 
Sublingual LAN significantly imprve exercise capacity at 45 but 
not at 100 minutes after administration. While these drugs appear 
to be useful as a prophylaxis for angina they should not be given 
on a fixed schedule 3 to 4 times a day as is currently the practice. 
THE ANTI-FIBRILLATORY EFFECT OF DIMETHYL QUATERNARY 
PROPRANOLOL (UM-272). 
Frank J. Kniffen, B.S.; Benedict R. Lucchesi, Ph.D., M.D.; 
University of Michigan Medical School, Ann Arbor, Mich. 
UM-272, (N,N,-Dimethyl-1-isopropylamino-3- I-naphthyloxyl 
propan-2-ol), a quaternary derivative of propranolol, 
lacks both -adrenergic receptor blocking activity and 
local anesthetic activity. UM-272 demonstrates anti- 
arrhythmic effectiveness against digitalis-induced 
arrhythmia, and ectopic ventricular rhythms occurring 48 
hrs. after two-stage coronsry ligation. The anti-fibril- 
latory effectiveness of the agent, in acute coronary 
artery ligation studies and fibrillation threshold 
measurements were performed in anesthetized mongrel dogs. 
Pretreatment with UM-272, 10 a&kg, lowered the incidence 
of ventricular fibrillation after a 20 min. single-stage 
coronary artery ligation from 100% to 40% in the treated 
group. The incidence of premature ventricular contrac- 
tions after treatment, was reduced to 20% from a control 
value of 100%. The vulnerability to fibrillation was 
assessed using trains of 60 Hz square wave pulses of 5 mA 
in intensity and 2 msec in duration. UM-272, 5 tug/kg, 
raised the mean fibrillation threshold from 322 msec 5 
20 SM to 599 msec + 76 SRM. an increase of 185%. After a 
total dose of 10 mg/kg, none of the five experimental 
animals fibrillated utilizing the ssme test parameters. 
When the strength of the 60 Hz pulse was raised to 10 mA, 
only short bursts of ventricular tachycardia were 
observed. The time course of vulnerability to fibril- 
lation after experimental coronary occlusion was studied 
in the presence and absence of UM-272. In control experi- 
ments, occlusion produced a 64% decrease in the duration 
of the train necessary to induce ventricular fibrillation. 
This was raised to 124% of control after UM-272, 5 mg/kg. 
The results indicate that UM-272 possesses potent anti- 
fibrillatory properties. 
gFFECTS OF SYMPATHETIC NERVE BRANCH STIMULATION ON VEN- 
TRICULAR RECOVERY PROPERTIES AND CARDIAC RHYTHM 
Fany Kralios, MD; Luis Martin, MD; Kay Millar, ND; Mary 
Jo Burgess, MD, University of Utah, Salt Lake City, Utah. 
The cardiac distribution of right and left stellate fi- 
bers has been shown to differ, providing an explanation 
for ECG neurogenic ST-T abnormalities. In the present 
study in 27 dogs distribution of individual nerves was 
determined by refractory period (RP) changes induced by 
stimulation of nerves distal to the stellate ganglia (SC). 
Basic and premature stimuli twice threshold voltage were 
applied sequentially at 20 ventricular epicardial or sev- 
eral septal sites. RP was taken as the earliest prema- 
ture stimulus resulting in propagated activation. On the 
left, stimulation of the ventrolateral cardiac nerve 
(VLCN) shortened RP's by 10 m set or more on the poste- 
rior cardiac surface and the ventromedial cardiac nerve 
(VMCN) affected anterior and posterior surfaces with 
varying distribution and also shortened RP's in the sep- 
tum. On the right, the recurrent cardiac nerve (RCN) 
shortened RP's in the septum and on the anterior surface, 
mainly of the right ventricle. Other nerve branches had 
inconsistent effects. RP changes were associated with T 
wave changes in an ECG Y lead. Right SG, RCN. and VMCN 
stimulation inverted T waves and left SG and VLCN elic- 
ited more upright T waves, findings which are predictable 
from the RP data. Rhythm changes included sinus tachy- 
cardia during right SG and stellate cardiac nerve stimu- 
lation and AV junctional tachycardia during left SG, RCN, 
and VLCN stimulation. Findings demonstrate localized but 
overlapping cardiac distribution of individual nerves, 
providing a mechanism for localized electrophysiologic 
and contractile effects of sympathetic activity. New in- 
formation includes the localization of sympathetic effer- 
ent pathways distal to the SG and the identification of 
efferent pathways to the interventricular septum. 
PROGNOSTIC FACTORS AFTER MYOCARDIAL INFARCTION IN THE 
CORONARY DRUG PROJECT (CDP) 
W. Krol, Ph.D., S. Tominaga, M.D., J. Stamler, M.D.,FACC, 
and H. Blackburn, M.D., FACC, for the Coronary Drug 
Project Research Group, University of Maryland, Baltimore 
Maryland 
In the CDP, a National Heart and Lung Institute Collabor- 
ative Trial, the natural history of infarction was studied 
in 2035 placebo-treated men, among which 265 died in 3 
years follow-up. A ranking procedure identified the 1st 
5 entry characteristics having the strongest independent 
contribution to mortality prediction: ST segment depres- 
sion in the resting ECG, cardiomegaly, diuretic therapy, 
ventricular conduction defects and intermittent claudi- 
cation. The next 5 in rank were ventricular premature 
bests, functional NYHA class, serum cholesterol level, 
size or extent of Q waves and resting heart rate. 
A multivariate risk score based on 5 factors discriminated 
those who eventually died as well as did one using 10,20, 
or 40 characteristics. Only 19 deaths actually occurred 
among men in the lowest quintile of predicted risk while 
ll7occurred in the upper quintile, a risk ratio of 6.2. 
48% of eventual deaths were concentrated in men identi- 
fied in the upper 20% of predicted risk. 
The validity and universality of the risk score was estab- 
lished in an independent population. Application of the 
score to a geographically different population of infarct 
patients acHeved similar predictive results. It allowed 
discrimination between men with 7-fold different risk of 
dying in a given period. This prognostic index should 
prove useful in several ways: effective classification of 
infarction patients for controlled therapeutic trials, 
identification of individuals at excess risk for closer 
monitoring, and--to the degree that risk can be modified- 
prevention of recurrent myocardial infarction. 
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